RxDoctor Payments Data

Albert Lin, MD

Clinical Cardiac Electrophysiology · Chicago, ILNPI 1508820218

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (55.3%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Boston Scientific at 59.5% of the total.

$47,927in general payments, 2019–2025

Across 172 payments — averaging $278.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$28K
  • Abbott$7K
  • Medtronic$4K
  • Philips North America LLC$4K
  • Cook Incorporated$3K
  • Biotronik Inc.$917
  • plus $643 from 9 others
$438,227in research payments, 2019–2025

Across 131 payments — averaging $3345.24 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$255K
  • Boston Scientific$160K
  • Atricure, Inc.$24K

What the payments were for

  • Consulting fees$7,05015%
  • Speaking & faculty fees$26,52555%
  • Travel & lodging$7,74616%
  • Food & beverage$6,57614%
  • Education$300%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$47,927 in reported general payments places this provider in the 75th percentile of 158 clinical cardiac electrophysiology providers in Illinois.

See all clinical cardiac electrophysiology providers in Illinois

Medicare billing

Part B allowed, 2024
$229,232
Medicare patients
735
Services billed
2,333

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban239$336,712
XareltoRivaroxaban66$78,385
MultaqDronedarone Hcl30$47,552
Dofetilide23$11,909
Metoprolol Succinate182$3,370
Amiodarone Hcl69$1,419
Flecainide Acetate34$1,336
Diltiazem 24hr Er (Cd)Diltiazem Hcl33$658
SotalolSotalol Hcl13$334
ClopidogrelClopidogrel Bisulfate20$250
Metoprolol Tartrate21$158
Lisinopril12$97
Carvedilol12$39

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →